Table 2.
Summary of Methods of hiPSC Neural Differentiation Relevant to Schizophrenia
| Species | Intended Cell Type | Purity | Method | Neuronal Characterization | Reference |
|---|---|---|---|---|---|
| Human | Cortical glutamatergic and GABAergic | Approaches 100% mixed cortical cells | Dual SMAD inhibition in the context of retinoids, followed by FGF2 treatment | Immunohistochemistry, gene expression, electrophysiology, and transplantation | Shi et al.,19 Mariani et al., 201218 |
| Human | Midbrain dopaminergic neurons | >80% | Dual SMAD inhibition followed by SHH and WNT stimulation | Immunohistochemistry, gene expression, electrophysiology, and transplantation | Chambers et al., 200919; Kriks et al., 201130,31 |